Cabotegravir is a long-acting HIV-1 integrase strand transfer inhibitor (INSTI) used to treat HIV-1 infection and as pre-exposure prophylaxis (PrEP) by preventing viral DNA from integrating into the host… Read more
![Chemical structure of (3S,11aR)-6-Hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2757656-11-2-3S11aR-6-Hydroxy-3-methyl-57-dioxo-23571111a-hexahydrooxazolo32-apyrido12-dpyrazine-8-carboxylic-acid.png&w=3840&q=75)
![Chemical structure of (3S,11aR)-6-Methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1335210-24-6-3S11aR-6-Methoxy-3-methyl-57-dioxo-23571111a-hexahydrooxazolo32-apyrido12-dpyrazine-8-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (3S,11aR)-N-(2,4-Difluorobenzyl)-3-methyl-5,7-dioxo-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2170827-76-4-3S11aR-N-24-Difluorobenzyl-3-methyl-57-dioxo-6-2S3R4S5S6R-345-trihydroxy-6-hydroxymethyltetrahydro-2H-pyran-2-yloxy-23571111a-hexahydroox.png&w=3840&q=75)
![Chemical structure of (3S,11aR)-N-(2,4-Difluorobenzyl)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1335210-25-7-3S11aR-N-24-Difluorobenzyl-6-methoxy-3-methyl-57-dioxo-23571111a-hexahydrooxazolo32-apyrido12-dpyrazine-8-carboxamide.png&w=3840&q=75)
![Chemical structure of (3S,11aR)-N-(2,6-Difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3S11aR-N-26-Difluorobenzyl-6-hydroxy-3-methyl-57-dioxo-23571111a-hexahydrooxazolo32-apyrido12-dpyrazine-8-carboxamide.png&w=3840&q=75)
![Chemical structure of (3S,11aR)-N-(2-Fluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2883234-42-0-3S11aR-N-2-Fluorobenzyl-6-hydroxy-3-methyl-57-dioxo-23571111a-hexahydrooxazolo32-apyrido12-dpyrazine-8-carboxamide.png&w=3840&q=75)
![Chemical structure of (3S,11aR)-N-(4-Fluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1309560-71-1-3S11aR-N-4-Fluorobenzyl-6-hydroxy-3-methyl-57-dioxo-23571111a-hexahydrooxazolo32-apyrido12-dpyrazine-8-carboxamide.png&w=3840&q=75)
![Chemical structure of (3S,11aR)-N-Benzyl-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2883234-41-9-3S11aR-N-Benzyl-6-hydroxy-3-methyl-57-dioxo-23571111a-hexahydrooxazolo32-apyrido12-dpyrazine-8-carboxamide.png&w=3840&q=75)
![Chemical structure of (S)-N-(2,4-Difluorobenzyl)-9-hydroxy-2-(1-hydroxypropan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2883234-39-5-S-N-24-Difluorobenzyl-9-hydroxy-2-1-hydroxypropan-2-yl-18-dioxo-18-dihydro-2H-pyrido12-apyrazine-7-carboxamide.png&w=3840&q=75)




































Cabotegravir is a long-acting HIV-1 integrase strand transfer inhibitor (INSTI) used to treat HIV-1 infection and as pre-exposure prophylaxis (PrEP) by preventing viral DNA from integrating into the host genome. To ensure the safety and efficacy of pharmaceutical formulations, laboratories utilize our extensive range of Cabotegravir reference standards, which are essential for rigorous quality control and regulatory compliance. This collection supports comprehensive impurity profiling and analytical method validation, featuring pharmacopeial and non-pharmacopeial impurities, such as glucuronides, oxidation products, and open-ring structures, which may arise during synthesis or degradation. Additionally, we provide stable isotope-labelled compounds, including deuterium-labelled variants, which serve as critical internal standards for accurate quantification in mass spectrometry and pharmacokinetic studies. These high-quality materials enable precise identification and monitoring of Cabotegravir and its related substances throughout the drug development lifecycle.